Yes, codeine is an opioid. It is derived from the opium poppy and classified alongside morphine, oxycodone, and hydrocodone as a controlled substance under federal law. Despite its reputation as a “mild” painkiller, codeine works through the same brain receptors as stronger opioids and carries similar risks, including dependence, respiratory depression, and overdose.
How Codeine Works in Your Body
Codeine is actually a prodrug, meaning it doesn’t do much on its own. After you swallow it, your liver converts it into morphine, and that morphine is what provides the pain relief. A specific liver enzyme handles this conversion, turning roughly a quarter of the codeine dose into active morphine that then binds to opioid receptors in your brain and spinal cord.
Once morphine reaches those receptors, it blocks pain signals from traveling between nerve cells. It also triggers the reward pathways that produce feelings of relaxation and mild euphoria. This is the same basic mechanism behind every opioid, from prescription painkillers to heroin. The difference is potency: codeine is about 15% as strong as an equivalent dose of oral morphine, making it one of the weakest opioids in clinical use.
What Codeine Is Prescribed For
Codeine is used to treat mild to moderate pain, typically at doses of 15 to 60 mg every four hours as needed. It’s also a common ingredient in prescription cough syrups, where it suppresses the cough reflex at the brainstem level. You’ll often find it combined with acetaminophen (as in Tylenol with Codeine) or with antihistamines in cough formulations.
Its Legal Classification Depends on the Dose
The DEA schedules codeine differently depending on how it’s packaged. Pure codeine is a Schedule II controlled substance, the same category as oxycodone, fentanyl, and morphine. Combination products containing no more than 90 mg of codeine per dose (like Tylenol with Codeine) drop to Schedule III. Cough preparations with very low concentrations, no more than 200 mg per 100 milliliters, are classified as Schedule V, the least restrictive category.
This tiered scheduling sometimes gives people the impression that codeine is barely an opioid. That impression is misleading. The scheduling reflects the lower concentration in combination products, not a fundamentally different level of risk.
Genetics Change How You Respond to Codeine
Because codeine relies on a liver enzyme for activation, your genetic makeup directly affects whether the drug works well, barely works, or becomes dangerous. People fall along a spectrum based on how many functional copies of the gene for that enzyme they carry.
Poor metabolizers have two inactive copies of the gene. Their bodies convert very little codeine into morphine, so they may get almost no pain relief at all. For these individuals, codeine is essentially an inactive pill, and an alternative painkiller is a better option.
On the other end, ultrarapid metabolizers carry extra copies of the gene and convert codeine into morphine faster and more completely than normal. Even at standard prescribed doses, they can end up with dangerously high morphine levels. Symptoms of this include extreme sleepiness, confusion, and shallow breathing. In some cases, it has been fatal. The FDA states that ultrarapid metabolizers should not use codeine at all.
Most people fall somewhere in the middle and process the drug as expected. But there’s no easy way to know where you fall without genetic testing, and most people taking codeine have never been tested. Estimates suggest that 1 to 2% of people of European descent, and up to 29% of people from certain North African and Middle Eastern populations, are ultrarapid metabolizers.
Risks in Children
The FDA added its strongest warning, a Boxed Warning, to codeine-containing products regarding use in children after surgery to remove tonsils or adenoids. Codeine is now contraindicated entirely for post-operative pain in children who’ve had these procedures, because it’s not practical to screen every child for ultrarapid metabolism before surgery. Several pediatric deaths linked to codeine toxicity prompted this change.
For other types of pain in children, codeine should only be given on an as-needed basis rather than on a fixed schedule, at the lowest effective dose, and for the shortest possible time. Parents should watch for unusual sleepiness, confusion, or noisy or difficult breathing, all signs that too much morphine is building up.
Side Effects and Dependence Risk
Codeine produces the same general side effects as other opioids: constipation, nausea, drowsiness, and dizziness. These are direct consequences of opioid receptor activation throughout the body, not just in the brain. Constipation, in particular, tends not to improve with continued use the way drowsiness often does.
The more serious risk is respiratory depression, where breathing becomes dangerously slow and shallow. This risk increases when codeine is combined with alcohol, sedatives, or other drugs that depress the central nervous system. It also increases in ultrarapid metabolizers and in anyone taking higher-than-prescribed doses.
Because codeine activates the same reward pathways as all opioids, it carries a real risk of dependence and addiction with repeated use. Physical dependence can develop in as little as a few weeks of regular use, leading to withdrawal symptoms like muscle aches, restlessness, and insomnia when the drug is stopped. The fact that codeine is weaker than morphine or oxycodone does not make it immune to misuse. Lower potency simply means the ceiling for pain relief is lower, not that the mechanism of addiction is any different.
How Codeine Compares to Other Opioids
Codeine sits at the bottom of the opioid potency ladder. At 0.15 times the strength of oral morphine, you’d need roughly 200 mg of codeine to match what 30 mg of morphine does. For comparison, oxycodone is about 1.5 times as potent as morphine, and fentanyl is roughly 50 to 100 times more potent.
This lower potency is why codeine has historically been used for mild pain and coughs rather than for post-surgical or cancer pain. But “weaker” is relative. At higher doses, or in people who metabolize it rapidly, codeine delivers enough morphine to cause the same life-threatening effects as any other opioid. Treating it casually because of its lower potency is one of the most common and most dangerous misunderstandings about the drug.